F52 – Reactivation of Epstein-Barr virus from latency
The general problem in cancer treatment centres on finding agents that specifically affect cancer cells without damaging normal cells. The differences…
F52 – Reactivation of Epstein-Barr virus from latency Tovább olvasom »